Minimal change glomerulonephritis with reversible proteinuria during interferon alpha 2a therapy for chronic myeloid leukemia.
Rettmar
K
K
Kienast
J
J
van de Loo
J
J
D000328:Adult; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D011507:Proteinuria / Q000139:chemically induced*
D016898:Interferon-alpha